APA (7th ed.) Citation

Hagino, T., Saeki, H., Fujimoto, E., & Kanda, N. Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Hagino, Teppei, Hidehisa Saeki, Eita Fujimoto, and Naoko Kanda. Effectiveness and Safety of Deucravacitinib Treatment for Moderate-to-severe Psoriasis in Real-world Clinical Practice in Japan. Taylor & Francis Group.

MLA (9th ed.) Citation

Hagino, Teppei, et al. Effectiveness and Safety of Deucravacitinib Treatment for Moderate-to-severe Psoriasis in Real-world Clinical Practice in Japan. Taylor & Francis Group.